Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Knownwell delivers hybrid in-person and virtual primary care with an emphasis on weight-inclusive metabolic health. It integrates evidence-based obesity medicine—including anti-obesity drugs like GLP‑1s—with nutrition counseling, behavioral support, remote monitoring, and AI-driven personalized treatment planning. The company has expanded rapidly since its 2023 launch through funding rounds and the acquisition of Alfie Health’s AI technology[2][3][4][5]. Clinical results are focused on patient engagement and holistic outcomes rather than traditional drug trial endpoints.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Knownwell.